EGFR and neoplasm: In a tumor study, EGFR C797S frequency was higher for 29% of cases and was preferentially coupled with EGFR exon 19 deletion compared to L858R (24% versus 11%), and was only seen in tumors that retained T790M, suggesting continued EGFR dependance in these tumors [70].